Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis
Puntos clave
The study aims to evaluate the effectiveness of oral prednisolone premedication in preventing infusion-related reactions to rituximab in rheumatoid arthritis patients.
Comparison of oral prednisolone with intravenous glucocorticoids
Assessment of infusion-related reactions in rheumatoid arthritis patients
Analysis of safety and efficacy outcomes
Oral prednisolone does not increase infusion-related reactions compared to intravenous glucocorticoids
Potential preference for oral administration due to additional advantages
Resumen
Oral prednisolone pretreatment to RTX does not result in more infusion-related reactions in patients with RA, and may therefore, based on other advantages, be preferable to intravenous glucocorticoids.
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis | Synapse